(British Society of Gastroenterology)
- Cold EMR, hot EMR or ESD for large benign adenoma: not one size fits all
- High-risk varices in patients with Child-Pugh-Turcotte B and C: consider band ligation with carvedilol for preventing first variceal bleeding, especially in patients with MASLD-associated cirrhosis
- Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer
- Targeting Wnt signalling through LINC02418: insights from CRISPR screens
- AlphaMissense versus laboratory-based pathogenicity prediction of 13 novel missense CPA1 variants from pancreatitis cases
- Metabolic dysfunction-associated steatotic liver disease in children
- Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?
- Statins for MAFLD/MASH: another brick in the wall while waiting for final answers
- Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
- Treatment of type 2 diabetes with MASLD: new evidence for personalised medicine
- Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long non-coding transcriptome
- Divergent lineage trajectories and genetic landscapes in human gastric intestinal metaplasia organoids associated with early neoplastic progression
- GI highlights from the literature
- Surveillance in inflammatory bowel disease: white light endoscopy with segmental re-inspection versus dye-based chromoendoscopy - a multi-arm randomised controlled trial (HELIOS)
- Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy
Esprimi il gradimento a questo contenuto
[Totale voti: 0 Media: 0]
